金双歧联合四君子合剂治疗婴幼儿厌食症疗效观察

目的 观察金双歧联合四君子合剂治疗小儿厌食症临床疗效.方法 将108例患儿按简单随机抽样法分为治疗组56例和对照组52例,两组均予口服金双歧治疗,治疗组联合四君子合剂治疗,观察两组患儿服药后食欲改善情况.连续治疗6周后,对两组疗效进行对比.结果 治疗组总有效率为92.1％;对照组总有效率为59.6％,两组比较差异有统计学意义(P＜0.05).结论 金双歧联合四君子合剂治疗小儿厌食症疗效显著,且安全无不良反应,值得临床推广应用.     

双歧杆菌治疗恢复期急性重症胰腺炎临床观察

目的 观察双歧杆菌治疗恢复期急性重症胰腺炎（SAP）临床疗效及肠道菌群变化。方法 将恢复期SAP病例随机分为对照组和治疗组,对照组给予常规治疗;而治疗组在给予常规治疗基础上加服回春生胶囊,疗程4周。均在治疗前后记录临床疗效,包括生化指标及肠道菌群变化。结果 治疗组与对照组治疗后各项指标时间比较差异均有显著性（P＜0.05,P＜0.01）;2组肠道菌群变化情况为对照组治疗前后肠道菌群未发生明显变化（P＞0.05）,而治疗组治疗后大肠埃希菌明显下降,双歧杆菌显著上升（P＜0.01）。结论 双歧杆菌治疗恢复期SAP疗效明显,值得临床应用。     

金双歧治疗小儿厌食症的临床研究

目的观察金双歧对小儿厌食的治疗效果。方法将54例有厌食症患儿随机分成治疗组和对照组各27例,分别用金双歧和醒脾养儿颗粒治疗,观察两组治疗后食欲提高的显效时间及总有效率。结果治疗组较对照组在平均显效时间及总有效率方面优于对照组,差异有统计学意义（P〈0．001,P〈0．05）。结论金双歧对小儿厌食症治疗有效。     

金双歧治疗急慢性腹泻的临床观察

金双歧是由长双歧杆菌、保家利亚乳杆菌、嗜热链球菌组成的活菌制剂。我院于1998年6月～1998年12月应用内蒙古双奇药业有限公司生产的金双歧[批号:(98)卫药试字(蒙双奇)S-01号]治疗急慢性腹泻64例,取得较好效果,现报告如下:1　材料与方法1.1　来源　本组应用金双歧治疗急?..     

双歧杆菌三联活菌胶囊联合营养支持治疗重症急性胰腺炎的临床研究

目的:探讨双歧杆菌三联活菌胶囊联合营养支持治疗重症急性胰腺炎的临床疗效。方法:选择2014年1月至2015年6月我院收治的90例重症急性胰腺炎患者作为研究对象,按照随机数字表法分为治疗组和对照组,每组45例患者。对照组在常规治疗基础上采用营养支持治疗,治疗组在对照组的基础上采用双歧杆菌三联活菌胶囊治疗。分别于治疗前后取患者静脉血进行C反应蛋白、白细胞介素-8、肿瘤坏死因子、白细胞计数、淀粉酶、脂肪酶、乳酸脱氢酶的检测,并对治疗效果和胃肠功能进行评分。结果:治疗组的总有效率95.56%显著高于对照组的80.00%,差异有统计学意义(P0.05)。治疗14 d后,两组患者的C反应蛋白、白细胞介素-8、肿瘤坏死因子、白细胞计数、淀粉酶、脂肪酶、乳酸脱氢酶水平均降低,且治疗组的下降幅度显著大于对照组,差异均有统计学意义(P0.05)。治疗后两组患者的胃肠功能评分均低于治疗前,且治疗组胃肠功能评分明显优于对照组,差异有统计学意义(P0.05)。结论:双歧杆菌三联活菌胶囊联合营养支持治疗重症急性胰腺炎可降低患者的血液指标,增强肠道功能,具有较好的临床疗效,临床可推广应用。     

双歧杆菌制剂对急性重症胰腺炎感染的治疗作用

目的：观察双歧杆菌制剂对急性重症胰腺炎感染的治疗作用。方法：收治9例急性重症胰腺炎患者投以双歧杆菌制剂,经临床观察及大便细菌培养。结果：双歧杆菌制剂可改善临床症状,细菌培养显示患者肠道双歧杆菌、乳酸杆菌总数明显增加,肠道菌群接近正常比例,结论：双歧杆菌制剂对急性重症胰腺炎合并感染有辅助治疗作用。     

金双歧、思密达联合治疗小儿急性腹泻病的疗效观察

目的探讨小儿急性腹泻病联用金双歧片及思密达治疗的临床疗效。方法对门诊、急诊及留察小儿急性腹泻患者116例,分成2组,用头孢羟氨苄联用思密达进行对照。结果治疗组(金双歧片 思密达)总有效率为98．2％,对照组(头孢羟氨苄 思密达)总有效率为84．5％。结论金双歧具有调节菌群平衡,抑制肠道内致病菌生长的作用,联用胃肠黏膜保护剂思密达治疗小儿急性腹泻病,疗效显著。     

双歧杆菌合剂促进急性坏死性胰腺炎肠粘膜损伤修复的 …

观察双歧杆菌合剂对急性坏死性胰腺炎犬肠粘膜损伤修复的作用。经主胰管注入牛磺胆酸钠和胰蛋白酶复制犬ＡＮＰ模型,观察ＡＮＰ时及双歧杆菌合剂治疗粘膜组织结构变化,肠组织蛋白,丙二醛含量及肠通透性改变,检测血中内毒素水平,脏器细菌培养。     

金双歧治疗腹泻临床应用研究

口服“双歧杆菌、乳杆菌、嗜热链球菌三联活菌片”属于微生态制剂,临床上用于治疗肠道菌群失调引起的腹泻、漫性腹泻、抗生素治疗无效的腹泻及便秘。其药效成份是长双歧杆菌、保加利亚乳杆菌、嗜热链球菌三种健康人体肠道正常生理性细菌,可在人体肠道中生长繁殖。其药理作用是通过直接补充人体正常生理细菌,调整肠道菌群平衡,抑制并清除肠道中对人具有潜在危害的细菌,从而达到治疗腹泻及便秘的目的。     

双歧杆菌合剂促进急性坏死性胰腺炎肠粘膜损伤修复的实验研究

观察双歧杆菌合剂对急性坏死性胰腺炎（ＡＮＰ）犬肠粘膜损伤修复的作用。经主胰管注入牛磺胆酸钠和胰蛋白酶复制犬ＡＮＰ模型,观察ＡＮＰ时及双歧杆菌合剂治疗后肠粘膜组织结构变化,肠组织蛋白、丙二醛（ＭＤＡ）含量及肠通透性改变,检测血中内毒素（ＬＰＳ）水平,脏器细菌培养。结果发现,双歧杆菌合剂治疗后,ＡＮＰ犬肠粘膜损害明显减轻,肠粘膜绒毛宽度、高度和面积显著增加,肠组织蛋白含量增加,肠通透性显著下降,血中ＬＰＳ水平下降１～２倍,脏器细菌易位率减少３７５％。结论：双歧杆菌合剂能显著促进ＡＮＰ时肠粘膜损伤的修复,保护肠屏障功能,减少肠道ＬＰＳ和细菌易位     

金双歧联合思密达治疗肝源性腹泻33例

目的:研究金双歧联合思密达治疗肝源性腹泻的疗效。方法:将66例肝源性腹泻的病人分为两组,治疗组及对照组各33例。两组均给予适当休息、合理饮食,积极护肝及对症支持等综合治疗;在此基础上,治疗组使用金双歧(2．0g,每日三次)联合思密达(3．0g,每日三次)治疗;对照组口服左氧氟沙星(0．2g,每日两次)治疗。疗程均为7天～14天。疗效判断标准:①显效:腹泻消失,大便成形,每日一次;②有效:腹泻次数明显减少或大便基本成形;③无效:症状无改善或大便次数增多。以显效和有效计算总有效率。结果:治疗组显效13例,有效17例,总有效率90．9%;对照组显效10例,有效6例,总有效率48．5%。两组疗效对比差异有统计学意义(x2=15．45,P＜0．001)。结论:金双歧联合思密达治疗肝源性腹泻疗效显著,值得临床推广应用。     

益生菌联合早期肠内营养治疗重症急性胰腺炎临床疗效的Meta分析

目的 系统性评价益生菌联合早期肠内营养对重症急性胰腺炎(sever acute pancreatitis,SAPP)的临床疗效.方法 计算机检索中国知网、万方数据库、维普期刊数据库、PubMed、Embase和The Co-chrane Library,收集关于益生菌联合早期肠内营养治疗SAP的临床随机对照试验(ran...     

连续性肾脏替代疗法治疗重症急性胰腺炎的临床观察

目的观察连续性肾脏替代疗法（CRRT）治疗重症急性胰腺炎（SAP）患者的疗效及预后。方法回顾性分析广西医科大学第一附属医院ICU 2006年5月～2012年2月收治的22例SAP患者的临床资料,比较CRRT治疗前,治疗后3、5、7天患者生命征,APACHEⅡ评分及白细胞、SCr、血AMS、血气等变化,记录腹部症状并统计并发症及死亡率。结果 22例患者死亡4例,死亡率18.20%。22例患者均有急性肾损伤;急性肺损伤/急性呼吸窘迫综合征/肺部感染发生率为81.82%,其中胸腔积液50%;MODS 45.45%;感染性休克13.64%;急性肝损伤、胰性脑病均为9.09%;DIC、ACS均为4.55%。与治疗前相比,CRRT治疗3天后,T、RR、WBC、血AMS、血乳酸、APACHⅡ评分均下降（P〈0.05）,pH升高（P〈0.05）;5天后,脉搏、SCr、CRP均下降（P〈0.05）,PaO2/FiO2升高（P〈0.05）。3～5天后临床症状及体征改善。MAP呈下降趋势,但差异无统计学意义（P〉0.05）。结论 CRRT能快速有效改善SAP患者病情,稳定生命征、改善血气分析指标、清除体内代谢毒素,入住ICU的SAP患者及早进行CRRT的效果较好。     

Proteomic profiling in an animal model of acute pancreatitis

Acute pancreatitis (AP) is an inflammatory disease of the pancreas, which evolves in approximately 20% of the patients to a severe illness associated with a high mortality rate. In this study, we performed a comparative proteomic analysis of pancreatic tissue extracts from rats with AP and healthy rodent controls in order to identify changes in protein expression related to the pathobiological processes of this disease. Pancreatic extracts from diseased and controls rats were analyzed by 2-DE and MS/MS. A total of 125 proteins were identified from both samples. Comparative analysis allowed the detection of 42 proteins or protein fragments differentially expressed between diseased and control pancreas, some of them being newly described in AP. Interestingly, these changes were representative of the main pathobiological pathways involved in this disease. We observed activation of digestive proteases and increased expression of various inflammatory markers, including several members of the alpha-macroglobulin family. We also detected changes related to oxidative and cell stress responses. Finally, we highlighted modifications of 14-3-3 proteins that could be related to apoptosis regulation. These results showed the interest of proteomic analysis to identify changes characterizing pancreatic tissue damage and, therefore, to highlight new potential biomarkers of AP.     

Correlation between the glucose level and the development of acute pancreatitis

Objective

To investigate the correlation between the level of glucose in serum and the development of acute pancreatitis (AP).

Alteration of Cpn60 expression in pancreatic tissue of rats with acute pancreatitis

The expression of heat-shock protein 60 (also known as chaperonin 60, Cpn60) in experimental acute pancreatitis (AP) is considered to play an active role in the prevention of abnormal enzyme accumulation and activation in pancreatic acinar cells. However, there are controversial results in the literature regarding the relationship between the abnormality of Cpn60 expression and AP onset and development. The purpose of this study was to investigate the alternations of Cpn60 expression and the relationship between the abnormal expression of Cpn60 and AP progression in rat severe acute pancreatitis (SAP) models. In this report, we induced SAP in Sprague–Dawley (SD) rats by reverse injection of sodium deoxycholate into the pancreatic duct, and examined the dynamic changes of Cpn60 expression in pancreatic tissues from different time points and at different levels with techniques of real-time PCR, western blotting, and immunohistochemistry. At 1 h after SAP induction, the expression of Cpn60 mRNA in the AP pancreatic tissues was higher than those in the sham-operation group and normal control group, but decreased sharply as the time period was extended, and there was a significant difference between 1 h and 10 h after SAP induction (p < 0.05). In the AP process, Cpn60 protein expression showed transient elevation as well, and the increased protein expression occurred predominantly in affected, but not totally destroyed, pancreatic acinar cells. As AP progressed, the pancreatic tissues were seriously damaged, leading to a decreased overall Cpn60 protein expression. Our results show a complex pattern of Cpn60 expression in pancreatic tissues of SAP rats, and the causality between the damage of pancreatic tissues and the decrease of Cpn60 level needs to be investigated further. Xue-Li Li and Kun Li contributed equally to this work.     

The role of oxygen radicals in experimental acute pancreatitis

Oxygen-derived free radicals mediate an important step in the initiation of experimental acute pancreatitis. Thereby, it seems that these reactive oxygen metabolites are generated at an early stage of disease. The source of the enhanced production of oxygen radicals still remains unclear. Experimentally, the efficiency of scavenger treatment varied between different models, whereby these differences depended on the experimental model and not on the form of pancreatitis which was induced. Most studies pretreated the experimental animals before inducing acute pancreatitis. This does not mirror the clinical reality, since patients are admitted to the hospital after onset of the disease. It was shown in Cerulein pancreatitis, however, that scavenger treatment also mitigated the pancreatic tissue damages after induction of acute pancreatitis. Moreover, antioxidant treatment also attenuated the extrapancreatic complications, thus improving the final outcome of the disease. The first indirect observations also suggest that in human acute recurrent and chronic pancreatitis, oxygen free radicals are generated and add to the damages seen. Therefore, well-defined controlled clinical studies with patients suffering from acute pancreatitis are needed to validate the role of oxygen radicals in this disease.     

早期肠内营养联合微生态制剂对重症急性胰腺炎患者的临床疗效及其对免疫功能的影响

目的 分析早期肠内营养联合微生态制剂对重症急性胰腺炎患者的临床疗效及其免疫功能的影响。 方法 选择我院2017年6月至2020年1月间收治的80例符合标准的重症急性胰腺炎患者为研究对象并随机分为观察组和对照组,每组40例。对照组患者给予早期肠内营养干预。观察组患者采用早期肠内营养加微生态制剂治疗。评估患者疗效,同时评估治疗前、治疗7 d及治疗14 d时患者腹内压、胃肠功能、免疫球蛋白、炎症因子、淀粉酶、血清脂肪酶、血清乳酸脱氢酶及T细胞亚群水平。 结果 观察组患者临床总有效率高于对照组(97.50% vs 80.00%,P+、CD4+水平和CD4+/CD8+比值显著高于对照组,而CD8+水平低于对照组(均P结论 早期肠内营养联合微生态制剂可显著提高重症急性胰腺炎患者的临床疗效,并改善患者免疫功能。     

肠内营养联合微生态制剂对重症胰腺炎患者的疗效

目的 观察肠内营养联合微生态制剂对重症胰腺炎患者细菌移位、免疫功能、炎症反应的影响.方法 选择我院2017年1月至2019年7月收治的200例重症胰腺炎患者为研究对象,根据治疗方法不同分为A组、B组、C组.A组患者采用肠外营养治疗,B组患者采用肠内营养治疗,C组患者采用肠内营养联合微生态制剂治疗.比较3组患者的治疗效果...